NeuroSense Therapeutics is a clinical stage Biotech company dedicated to providing a novel, disease-modifying drug for ALS.

We are currently raising capital in order to execute a compassionate use study in the United States, and in order to prepare for a robust Phase II/III clinical trial in several sites in the United States and Israel.

We invite you to take part in our program and accelerate the clinical development towards a cure for ALS patients.

You are welcome to contact us at: